Articles published in Cancer Science & Therapy have been cited by esteemed scholars and scientists all around the world.
Cancer Science & Therapy has got h-index 27, which means every article in Cancer Science & Therapy has got 27 average citations.
Following are the list of articles that have cited the articles published in Cancer Science & Therapy.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|---|---|
Total published articles |
57 | 46 | 70 | 59 | 42 | 78 | 71 |
Research, Review articles and Editorials |
3 | 4 | 18 | 22 | 27 | 26 | 69 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
41 | 45 | 52 | 37 | 15 | 52 | 2 |
Conference proceedings |
0 | 21 | 45 | 12 | 0 | 162 | 404 |
Citations received as per Google Scholar, other indexing platforms and portals |
4129 | 3358 | 294 | 348 | 345 | 373 | 344 |
Journal total citations count | 5332 |
Journal impact factor | 2.06 |
Journal 5 years impact factor | 2.85 |
Journal cite score | 6.17 |
Journal h-index | 27 |
Journal h-index since 2019 | 18 |
Radiation Resistance: A Matter of Transcription Factors |
|
Bayesian Analysis of Cancer Data Using a 4-Component Exponential Mixture Model |
|
Longer Hydroxyurea Administration Prior to Imatinib Mesylate is Risk Factor for Unsuccessful Major Molecular Response in Chronic-Phase Chronic Myeloid Leukemia: Possibility of P-Glycoprotein Role |
|
The prognostic outcome of ‘type 2 diabetes mellitus and breast cancer’ association pivots on hypoxia-hyperglycemia axis |
|
The role of Hypoxia-Inducible Factor-1alpha and its signaling in melanoma |
|
The pathways related to glutamine metabolism, glutamine inhibitors and their implication for improving the efficiency of chemotherapy in triple-negative breast cancer |
|
Camphorataimide B, a maleimide in mycelium of Antrodia camphorate, inhibits progression of human MDA-MB-231 breast cancer cells |
|
CD73 facilitates EMT progression and promotes lung metastases in triple?negative breast cancer |
|
Inflammation, a key Factor in Cancer Ambush |
|
A MATHEMATICAL APPROACH OF EXPLORATION TOWARDS EXTREME RISK FACTOR IN CANCER OF OPTIMAL CONDITION |
|
A Glimpse on Melanoma - Risk Factors and Treatment |
|
A Short Note on Cancer |
|
Comparative assessment of HIF-1? and Akt responses in human lung and skin cells exposed to benzo[?]pyrene: Effect of conditioned medium from pre-exposed primary fibroblasts |
|
Targeting HIF-2? as therapy for advanced cancers |
|
Anticancer efficacy of noble metal nanoparticles relies on reprogramming tumor-associated macrophages through redox pathways and pro-inflammatory cytokine cascades |
|
Prolyl hydroxylase inhibitors act as agents to enhance the efficiency of cell therapy |
|
Expressions of Collagen I and III in Hypoxic Keloid Tissue |
|
Prolyl hydroxylase 2: a promising target to inhibit hypoxia-induced cellular metabolism in cancer cells |
|
RLIP76 regulates HIF-1 activity, VEGF expression and secretion in tumor cells, and secretome transactivation of endothelial cells |
|
The Histone Methyltransferase Inhibitor BIX01294 Inhibits HIF-1? Stability and Angiogenesis |
|
Cancer Science & Therapy received 5332 citations as per Google Scholar report